CN101657200A - 新型β-内酰胺抗生素、其制备方法及用途 - Google Patents

新型β-内酰胺抗生素、其制备方法及用途 Download PDF

Info

Publication number
CN101657200A
CN101657200A CN200880003805A CN200880003805A CN101657200A CN 101657200 A CN101657200 A CN 101657200A CN 200880003805 A CN200880003805 A CN 200880003805A CN 200880003805 A CN200880003805 A CN 200880003805A CN 101657200 A CN101657200 A CN 101657200A
Authority
CN
China
Prior art keywords
acid
formula
active component
beta
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880003805A
Other languages
English (en)
Chinese (zh)
Inventor
W-D·于利希
U·林德奎斯特
A·米科拉什
S·维特
F·绍尔
R·奥默
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dritte Patentportfolio Beteiligungs GmbH and Co KG
Original Assignee
Dritte Patentportfolio Beteiligungs GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dritte Patentportfolio Beteiligungs GmbH and Co KG filed Critical Dritte Patentportfolio Beteiligungs GmbH and Co KG
Publication of CN101657200A publication Critical patent/CN101657200A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN200880003805A 2007-01-31 2008-01-31 新型β-内酰胺抗生素、其制备方法及用途 Pending CN101657200A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07101519.2 2007-01-31
EP07101519 2007-01-31
PCT/EP2008/051214 WO2008092928A2 (de) 2007-01-31 2008-01-31 NEUE ß-LACTAM-ANTIBIOTIKA, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG

Publications (1)

Publication Number Publication Date
CN101657200A true CN101657200A (zh) 2010-02-24

Family

ID=39319703

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880003805A Pending CN101657200A (zh) 2007-01-31 2008-01-31 新型β-内酰胺抗生素、其制备方法及用途

Country Status (10)

Country Link
US (1) US20110040086A1 (ja)
EP (1) EP2120960A2 (ja)
JP (1) JP2010516800A (ja)
KR (1) KR20090104891A (ja)
CN (1) CN101657200A (ja)
AU (1) AU2008209747A1 (ja)
BR (1) BRPI0807466A2 (ja)
CA (1) CA2677044A1 (ja)
RU (1) RU2009132521A (ja)
WO (1) WO2008092928A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
JP5745303B2 (ja) * 2011-03-29 2015-07-08 株式会社シナネンゼオミック 抗微生物用水処理剤および水処理方法
GB201117538D0 (en) * 2011-10-11 2011-11-23 Royal Veterinary College The Methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2631146A (en) * 1952-11-13 1953-03-10 American Cyanamid Co Biguanide salts of penicillin
GB1434040A (en) * 1973-08-06 1976-04-28 Ici Ltd Process for combating fungi and bacteria
US20020146385A1 (en) * 2001-04-10 2002-10-10 Lin Tung Liang Ionic antimicrobial coating
EP1438975B1 (en) * 2003-01-16 2005-11-16 Xylos Corporation Microbial-derived cellulose amorphous hydrogel wound dressing
WO2006052201A1 (en) * 2004-11-10 2006-05-18 Neobiotics Ab Use of derivatives of dipeptides for the manufacture of a medicament for the treatment of microbial infections

Also Published As

Publication number Publication date
BRPI0807466A2 (pt) 2014-05-06
KR20090104891A (ko) 2009-10-06
AU2008209747A1 (en) 2008-08-07
EP2120960A2 (de) 2009-11-25
WO2008092928A9 (de) 2010-04-29
WO2008092928A2 (de) 2008-08-07
JP2010516800A (ja) 2010-05-20
US20110040086A1 (en) 2011-02-17
CA2677044A1 (en) 2008-08-07
WO2008092928A3 (de) 2009-02-12
WO2008092928A4 (de) 2009-04-02
RU2009132521A (ru) 2011-03-10

Similar Documents

Publication Publication Date Title
KR101955636B1 (ko) 항생제 그리고 분산제 또는 항-부착제를 포함하는 조성물
KR101749659B1 (ko) 신규한 용도
EP2922537B1 (en) Antibacterial composition for topical use
CN111870601B (zh) 一种6-二甲氨基喹啉芳香乙烯衍生物在制备抗耐药菌药物中的应用
CN101657200A (zh) 新型β-内酰胺抗生素、其制备方法及用途
Babaiwa et al. Antimicrobial and time-kill kinetics of the aqueous extract of Citrullus lanatus (Thunb.) seeds
EP2317998B1 (en) Fulvic acid and antibiotic combination
Shehabeldine et al. Wound Dressing Scaffold with High Anti-biofilm Performance Based on Ciprofloxacin-Loaded Chitosan-Hydrolyzed Starch Nanocomposite: In Vitro and In Vivo Study
US6224863B1 (en) Antibiotic composition from alcaligenes species and method for making and using the same
Arayne et al. Antibacterial studies of cefixime copper, zinc and cadmium complexes
CN109528710A (zh) 含有苯基噻吩类化合物的组合物
Al-Smail et al. Biological Activity of Active Compounds Extracts Tannins, Alkaloids, Glycosides and Saponins from Cuscuta lehmanniana.
CN114099507B (zh) 抗组胺药类药物在制备抗菌药物中的应用
CN111973571B (zh) 基于小檗碱衍生物及鼠李糖脂的抗菌纳米粒
WO2024013586A1 (en) Injectable herbal ointment for the treatment of subclinical mastitis: combining spirulina algae extract and mangrove leaf extract
TWI687229B (zh) 具有協同作用之生醫材料及其製造方法
US10398664B2 (en) Methods of diagnosing and treating infected implants
TWI736995B (zh) 新穎小分子化合物及其用途
ES2585929B1 (es) Cepa bacteriana de pseudonocardia carboxydivorans productora de branimicinas y branimicinas producidas por la misma
CA2681500A1 (en) Antibacterial compositions comprising an extract from arceuthobium
CA2664124A1 (fr) Nouvelle classe de composes derives de terpene a activite antibiotique, compositions les contenant et utilisations
Waksman Antibiotic Substances, Production by Microörganisms—Nature and Mode of Action
CN1796376A (zh) 抗菌化合物b－4及其在制备抗菌药物上的应用
ES2752040A1 (es) Cepa bacteriana de Streptomyces Althioticus productora de desertomicinas y desertomicina producida por la misma
CN109481445A (zh) 含有吗啉酮类化合物的组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100224